Literature DB >> 30267454

Myocardial recovery after cardiac resynchronization therapy in left bundle branch block-associated idiopathic nonischemic cardiomyopathy: A NEOLITH II substudy.

Norman C Wang1, Aliza Hussain1, Evan C Adelstein1, Andrew D Althouse1, Michael S Sharbaugh1, Sandeep K Jain1, Alaa A Shalaby1, Andrew H Voigt1, Samir Saba1.   

Abstract

BACKGROUND: Baseline predictors of myocardial recovery after cardiac resynchronization therapy (CRT) in left bundle branch block (LBBB)-associated idiopathic nonischemic cardiomyopathy (NICM) are unknown.
METHODS: A retrospective study included subjects with idiopathic NICM, left ventricular ejection fraction (LVEF) ≤35%, and LBBB. Myocardial recovery was defined as post-CRT LVEF ≥50%. Logistic regression analyses described associations between baseline characteristics and myocardial recovery. Cox regression analyses estimated the hazard ratio (HR) between myocardial recovery status and adverse clinical events.
RESULTS: In 105 subjects (mean age 61 years, 44% male, mean initial LVEF 22.6% ± 6.6%, 81% New York Heart Association class III, and 98% CRT-defibrillators), myocardial recovery after CRT was observed in 56 (54%) subjects. Hypertension, heart rate, and serum blood urea nitrogen (BUN) had negative associations with myocardial recovery in univariable analyses. These associations persisted in multivariable analysis: hypertension (odds ratio (OR), 0.40; 95% confidence interval (CI), 0.17-0.95; p = 0.04), heart rate (OR per 10 bpm, 0.69; 95% CI, 0.48-0.997; p = 0.048), and serum BUN (OR per 1 mg/dl, 0.94; 95% CI, 0.88-0.99; p = 0.04). Subjects with post-CRT LVEF ≥50%, when compared to <50%, had lower risk for adverse clinical events (heart failure hospitalization, appropriate implantable cardioverter-defibrillator shock, appropriate anti-tachycardia pacing therapy, ventricular assist device implantation, heart transplantation, and death) over a median follow-up of 75.9 months (HR, 0.38; 95% CI, 0.16-0.88; p = 0.02).
CONCLUSION: In LBBB-associated idiopathic NICM, myocardial recovery after CRT was associated with absence of hypertension, lower heart rate, and lower serum BUN. Those with myocardial recovery had fewer adverse clinical events.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  cardiac resynchronization therapy; left bundle branch block; left ventricular ejection fraction; myocardial recovery; nonischemic cardiomyopathy; outcomes

Mesh:

Year:  2018        PMID: 30267454      PMCID: PMC6931814          DOI: 10.1111/anec.12603

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  47 in total

1.  New-onset left bundle branch block-associated idiopathic nonischemic cardiomyopathy and left ventricular ejection fraction response to guideline-directed therapies: The NEOLITH study.

Authors:  Norman C Wang; Madhurmeet Singh; Evan C Adelstein; Sandeep K Jain; G Stuart Mendenhall; Alaa A Shalaby; Andrew H Voigt; Samir Saba
Journal:  Heart Rhythm       Date:  2015-12-11       Impact factor: 6.343

2.  Permanent His-bundle pacing for cardiac resynchronization therapy: Initial feasibility study in lieu of left ventricular lead.

Authors:  Olujimi A Ajijola; Gaurav A Upadhyay; Carlos Macias; Kalyanam Shivkumar; Roderick Tung
Journal:  Heart Rhythm       Date:  2017-04-08       Impact factor: 6.343

3.  Relationship between left ventricular lead position using a simple radiographic classification scheme and long-term outcome with resynchronization therapy.

Authors:  Stephen B Wilton; Mariko A Shibata; Rachel Sondergaard; Karen Cowan; Lisa Semeniuk; Derek V Exner
Journal:  J Interv Card Electrophysiol       Date:  2008-08-08       Impact factor: 1.900

4.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  Circulation       Date:  2013-06-05       Impact factor: 29.690

5.  Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.

Authors:  Yitschak Biton; Arthur J Moss; Valentina Kutyifa; Andrew Mathias; Saadia Sherazi; Wojciech Zareba; Scott McNitt; Bronislava Polonsky; Alon Barsheshet; Mary W Brown; Ilan Goldenberg
Journal:  Circ Heart Fail       Date:  2015-07-15       Impact factor: 8.790

6.  Myocardial recovery after cardiac resynchronization therapy in left bundle branch block-associated idiopathic nonischemic cardiomyopathy: A NEOLITH II substudy.

Authors:  Norman C Wang; Aliza Hussain; Evan C Adelstein; Andrew D Althouse; Michael S Sharbaugh; Sandeep K Jain; Alaa A Shalaby; Andrew H Voigt; Samir Saba
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-09-28       Impact factor: 1.468

Review 7.  Physiological mechanisms of QRS narrowing in bundle branch block patients undergoing permanent His bundle pacing.

Authors:  Alexandra E Teng; Louis Massoud; Olujimi A Ajijola
Journal:  J Electrocardiol       Date:  2016-07-16       Impact factor: 1.438

8.  Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis.

Authors:  Harsh Golwala; Navkaranbir Singh Bajaj; Garima Arora; Pankaj Arora
Journal:  Circulation       Date:  2016-12-19       Impact factor: 29.690

9.  Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.

Authors:  Martin H Ruwald; Scott D Solomon; Elyse Foster; Valentina Kutyifa; Anne-Christine Ruwald; Saadia Sherazi; Scott McNitt; Christian Jons; Arthur J Moss; Wojciech Zareba
Journal:  Circulation       Date:  2014-10-09       Impact factor: 29.690

10.  Impaired Recovery of Left Ventricular Function in Patients With Cardiomyopathy and Left Bundle Branch Block.

Authors:  Edward Sze; Zainab Samad; Allison Dunning; Kristen Bova Campbell; Zak Loring; Brett D Atwater; Karen Chiswell; Joseph A Kisslo; Eric J Velazquez; James P Daubert
Journal:  J Am Coll Cardiol       Date:  2018-01-23       Impact factor: 24.094

View more
  3 in total

1.  Myocardial recovery after cardiac resynchronization therapy in left bundle branch block-associated idiopathic nonischemic cardiomyopathy: A NEOLITH II substudy.

Authors:  Norman C Wang; Aliza Hussain; Evan C Adelstein; Andrew D Althouse; Michael S Sharbaugh; Sandeep K Jain; Alaa A Shalaby; Andrew H Voigt; Samir Saba
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-09-28       Impact factor: 1.468

2.  Sex-specific clinical outcomes after cardiac resynchronization therapy in left bundle branch block-associated idiopathic nonischemic cardiomyopathy: A NEOLITH II substudy.

Authors:  Norman C Wang; Ure Mezu-Chukwu; Evan C Adelstein; Andrew D Althouse; Michael S Sharbaugh; Sandeep K Jain; Alaa A Shalaby; Andrew H Voigt; Samir Saba
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-03-27       Impact factor: 1.468

3.  Short QRS Duration After His-Purkinje Conduction System Pacing Predicts Left Ventricular Complete Reverse Remodeling in Patients With True Left Bundle Branch Block and Heart Failure.

Authors:  Xu-Min Guan; Dan-Na Li; Fu-Lu Zhao; Yan-Ni Zhao; Yi-Heng Yang; Bai-Ling Dai; Shi-Yu Dai; Lian-Jun Gao; Yun-Long Xia; Ying-Xue Dong
Journal:  Front Cardiovasc Med       Date:  2022-05-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.